Rickets Clinical Trials

Find Rickets Clinical Trials Near You

Chronic Kidney Disease -Mineral and Bone Disorder, The CPH-MBD Cohort

Status: Recruiting
Location: See location...
Study Type: Observational
SUMMARY

Persons with chronic kidney disease (CKD) have a 3-fold increased risk of bone fracture and a 10-fold increased risk of cardiovascular disease than the general population. These increased risks are related to the disturbances in the mineral metabolism, and this clinical entity is termed Chronic Kidney Disease - Mineral and Bone Disorder (CKD-MBD). The overall aim of the present project is to explore factors that may predict or associate with the development of bone and cardiovascular disease in patients with CKD and hopefully provide insight into underlying mechanisms and pathophysiological pathways for future treatment and prevention. In a sub study investigators aim to explore the calcium and phosphate balance in patients with CKD and describe how these associate with each other as well as with kidney function (eGFR).

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• Age ≥18 years

• CKD stage 4-5nonD (eGFR ≤ 29 ml/min) according to KDIGO (Kidney Disease Improving Global Outcome) definition

Locations
Other Locations
Denmark
Department of Nephrology, outpatient clinic, Herlev Hospital
RECRUITING
Herlev
Contact Information
Primary
Freja S Hassager, Medical doctor
freja.staehr.hassager.01@regionh.dk
+4522554707
Time Frame
Start Date: 2026-01-07
Estimated Completion Date: 2055-01
Participants
Target number of participants: 1000
Treatments
CPH-MBD cohort
Participants will be followed-up for 25 years after inclusion. Bone fractures, cardiovascular events, progression of kidney disease, end-stage kidney disease and death will be collected through linkage with registries during follow-up.~There is no intervention in this study.
Detailed dietary assessment
From the CPH-MBD cohort we invite 50 participants to complete a dietary assessment to obtain more accurate information about their calcium and phosphate intake.
Sponsors
Leads: Herlev Hospital

This content was sourced from clinicaltrials.gov